Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Ck Chung

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Nephrology and Renovascular Disease|October 11, 2013
MicroRNA and nephropathy: emerging conceptsArthur Ck Chung, Xueqing Yu, Hui Y Lan
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2014
MicroRNA-29b inhibits diabetic nephropathy in db/db miceHai-Yong Chen, Xiang Zhong, Xiao R Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2012
miR-29 inhibits bleomycin-induced pulmonary fibrosis in miceJun Xiao, Xiao-Ming Meng, Xiao R Huang, et al.
American Journal of Translational Research|July 4, 2017
Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney diseaseXiang Zhong, Yue Ju Tu, Yi Li, et al.
Gut|January 12, 2021
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19Yun Kit Yeoh, Tao Zuo, Grace Chung-Yan Lui, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Nephrology and Renovascular Disease|October 11, 2013
MicroRNA and nephropathy: emerging conceptsArthur Ck Chung, Xueqing Yu, Hui Y Lan
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2014
miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signalingYang Zhang, Xiao-Ru Huang, Li-Hua Wei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2014
MicroRNA-29b inhibits diabetic nephropathy in db/db miceHai-Yong Chen, Xiang Zhong, Xiao R Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 8, 2012
miR-29 inhibits bleomycin-induced pulmonary fibrosis in miceJun Xiao, Xiao-Ming Meng, Xiao R Huang, et al.
American Journal of Translational Research|July 4, 2017
Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney diseaseXiang Zhong, Yue Ju Tu, Yi Li, et al.
Gut|January 12, 2021
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19Yun Kit Yeoh, Tao Zuo, Grace Chung-Yan Lui, et al.
Pageof 1